Advertisement
The Body: The Complete HIV/AIDS Resource
Follow Us Follow Us on Facebook Follow Us on Twitter Download Our App
Professionals >> Visit The Body PROThe Body en Espanol
Read Now: TheBodyPRO.com Covers AIDS 2014
  
  • Email Email
  • Glossary Glossary

HIV JournalView


  • No Longer Cured: HIV Relapse in "Mississippi Child" Raises New Questions (July 10, 2014)
    In HIV JournalView, from TheBodyPRO.com
  • Revised CDC Guidelines for HIV Testing Encourage Earlier Diagnoses (July 2, 2014)
    The updated guidelines recommend using a fourth-generation HIV test, which can detect HIV four to seven days sooner than standard antibody tests.
    In HIV JournalView, from TheBodyPRO.com
  • Primary Care Guidelines for HIV-Infected Patients Get First Overhaul in 4 Years (December 19, 2013)
    The updated HIVMA guidelines arrive at an important juncture in the evolution of HIV care, particularly given the "routinization" of HIV patient management in the U.S.
    In HIV JournalView, from TheBodyPRO.com
  • Top 10 HIV Clinical Developments of 2013 (December 8, 2013)
    Every year, thousands of research studies on HIV are presented and published. David Wohl, M.D., walks us through some of those whose findings may have the greatest affect on the way health care professionals prevent HIV transmission and treat people who are living with the virus.
    In HIV JournalView, from TheBodyPRO.com
  • Is Your Patient's HIV Diagnosis Truly New? Antiretroviral Drug Testing May Provide Verdict (November 25, 2013)
    In HIV JournalView, from TheBodyPRO.com
  • No Increase in Heart Attacks Among HIV-Infected People With High CD4+ Cell Counts (October 28, 2013)
    In HIV JournalView, from TheBodyPRO.com
  • Low HIV Viral Load May Reduce Anal Cancer Risk; Spontaneous Regression Is Common (June 21, 2013)
    In HIV JournalView, from TheBodyPRO.com
  • HIV Eradication Moves One Small Step Closer as Stem Cell Transplant Findings Titillate (May 30, 2013)
    A Boston study seeks to answer the question: What if the stem cell transplant that functionally cured Timothy Brown was made just a little bit easier?
    In HIV JournalView, from TheBodyPRO.com
  • No Excess Death Among HIV-Infected People -- as Long as CD4+ Cell Counts Are Kept Close to Normal (March 15, 2013)
    A new study gives us the most conclusive evidence to date that HIV-positive people who take their meds and keep their CD4 count above 500 are just as healthy overall as HIV-negative people.
    In HIV JournalView, from TheBodyPRO.com
  • Dangers of Smoking Greatly Enhanced for HIV-Infected Patients, Study Finds (February 21, 2013)
    A recently published study from a national cohort of HIV-infected Danes supplies a bunch of new facts that you can use to scare -- er, counsel -- your patients afflicted with tobaccoism.
    In HIV JournalView, from TheBodyPRO.com
  • Top 10 HIV Clinical Developments of 2012 (December 2012)
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView: October/November 2012 (November 27, 2012)
    David Alain Wohl, M.D., looks at new findings regarding racial disparities in HIV care, predicting hospital readmissions, sexual transmission of HCV, treatment of diabetes, and more accurate/efficient ways to measure and predict adherence.
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView: September 2012 (October 15, 2012)
    David Alain Wohl, M.D., explores recently published findings regarding access to HIV care in the U.S., the impact of pain on clinic no-shows, links between atazanavir and gall/kidney stones, anal sex and HIV among women, and the limits of echocardiography.
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView (October/November 2007)
    Breaking research on malignancies, metabolic complications, darunavir resistance, sperm washing and more -- concise analysis from David Wohl, M.D.
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView (September 2007)
    Among other reviews this month, David Wohl, M.D., looks at the latest studies on entecavir and HIV drug resistance and examines how saturated fat intake contributes to HIV-associated hypertriglyceridemia.
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView (July 2007)
    Among other stories this month, Graeme Moyle, M.D., reviews the potential for shifting HIV tropism and what this means to the use of CCR5 antagonists.
    In HIV JournalView, from TheBodyPRO.com
  • Top 10 HIV Medical Stories of 2006 (February 2007)
    It's one of the most insightful, entertaining, informative HIV research recaps you'll read this year: The Body PRO's David Wohl, M.D., presents an end-of-year review of the developments that made the biggest waves among HIV health care professionals in 2006. If you're looking for an easy-to-digest recap of the most critical news in HIV over the last calendar year, this is the article to read.
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView (September/October 2006)
    Pablo Tebas, M.D., analyzes recently published research on: the utility (or lack thereof) of viral load tests in predicting the rate of CD4+ cell decline; the tendency for HIV-infected patients to have a poorer prognosis when diagnosed with lung cancer than their HIV-uninfected counterparts; the potential for drug interactions between enfuvirtide and ritonavir-boosted tipranavir; and the high prevalence of human papillomavirus infection among sexually active men.
    To read PDF, click here.
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView (May/June 2006)
    David Wohl, M.D., examines published research on the quantifiable benefits of HIV care; predicting response to atazanavir/ritonavir; the need for baseline resistance testing; widespread belief in HIV conspiracy theories; adherence and risk-reduction interventions; and recent patterns in body fat changes among HAART patients.
    To read PDF, click here.
    In HIV JournalView, from TheBodyPRO.com
  • HIV JournalView (February/March 2006)
    David Wohl, M.D., analyzes a head-to-head comparison of tenofovir + emtricitabine + efavirenz versus zidovudine/lamivudine + efavirenz in treatment-naive patients; the relationship between antiretroviral class, adherence and resistance; the successes and limitations of HAART in the developing world; and mixed news on investigational enfuvirtide administrations (good news on needle-free administration; bad news on once-daily dosing).
    To read PDF, click here.
    In HIV JournalView, from TheBodyPRO.com
  • Top 10 Research Publications in HIV Care of 2005 (January 2006)
    Thousands of HIV-related studies were published in 2005, but only a handful heralded fundamental changes in the way we approach HIV screening and treatment; David Wohl, M.D., recaps these critical studies and explains their significance in this issue of HIV JournalView.
    To read PDF, click here.
    From TheBodyPRO.com

  • 1 | 2 Next >


  
  • Email Email
  • Glossary Glossary
Advertisement